Free Shipping On Orders Over $1,000!

SUFU Monoclonal Antibody

Applications

  • WB
  • IHC-P

Predicted Reactivity

  • Human
  • Mouse
  • Monkey
Overview
Catalog # bsm-51651M
Product Name SUFU Monoclonal Antibody
Applications WB, IHC-P
Predicted Reactivity Human, Mouse, Monkey
Specifications
Conjugation Unconjugated
Host Mouse
Source Recombinant human SUFU.
Clonality Monoclonal
Clone # D6S12
Concentration 0.5ug/ul
Storage Buffer 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID 51684
Swiss Prot Q9UMX1
Subcellular location Cytoplasm, Nucleus
Synonyms SU FU; SU(F)U; Su(fu); SUFU_HUMAN; SUFUH; SUFUXL; Suppressor of fused homolog (Drosophila); Suppressor of fused homolog; OTTHUMP00000020374; OTTHUMP00000020377; OTTHUMP00000020379; PRO1280.
Background Negative regulator in the hedgehog signaling pathway. Down-regulates GLI1-mediated transactivation of target genes. Part of a corepressor complex that acts on DNA-bound GLI1. May also act by linking GLI1 to BTRC and thereby targeting GLI1 to degradation by the proteasome. Sequesters GLI1, GLI2 and GLI3 in the cytoplasm, this effect is overcome by binding of STK36 to both SUFU and a GLI protein. Negative regulator of beta-catenin signaling. Regulates the formation of either the repressor form (GLI3R) or the activator form (GLI3A) of the full length form of GLI3 (GLI3FL). GLI3FL is complexed with SUFU in the cytoplasm and is maintained in a neutral state. Without the Hh signal, the SUFU-GLI3 complex is recruited to cilia, leading to the efficient processing of GLI3FL into GLI3R. When Hh signaling is initiated, SUFU dissociates from GLI3FL and the latter translocates to the nucleus, where it is phosphorylated, destabilized, and converted to a transcriptional activator (GLI3A).
Application Dilution
WB =1:500-2000,IHC-P=1:25,IHC-F=1:25,
IHC-P 1:200-400